Abstract
Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised.
Author supplied keywords
Cite
CITATION STYLE
Zahr, R., & Fleseriu, M. (2018, September 1). Updates in diagnosis and treatment of acromegaly. European Endocrinology. Touch Briefings. https://doi.org/10.17925/EE.2018.14.2.57
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.